Literature DB >> 28625870

Pax3- and Pax7-mediated Dbx1 regulation orchestrates the patterning of intermediate spinal interneurons.

Chris Gard1, Gloria Gonzalez Curto1, Youcef El-Mokhtar Frarma1, Elodie Chollet1, Nathalie Duval2, Valentine Auzié1, Frédéric Auradé3, Lisa Vigier1, Frédéric Relaix4, Alessandra Pierani1, Frédéric Causeret5, Vanessa Ribes6.   

Abstract

Transcription factors are key orchestrators of the emergence of neuronal diversity within the developing spinal cord. As such, the two paralogous proteins Pax3 and Pax7 regulate the specification of progenitor cells within the intermediate neural tube, by defining a neat segregation between those fated to form motor circuits and those involved in the integration of sensory inputs. To attain insights into the molecular means by which they control this process, we have performed detailed phenotypic analyses of the intermediate spinal interneurons (IN), namely the dI6, V0D, V0VCG and V1 populations in compound null mutants for Pax3 and Pax7. This has revealed that the levels of Pax3/7 proteins determine both the dorso-ventral extent and the number of cells produced in each subpopulation; with increasing levels leading to the dorsalisation of their fate. Furthermore, thanks to the examination of mutants in which Pax3 transcriptional activity is skewed either towards repression or activation, we demonstrate that this cell diversification process is mainly dictated by Pax3/7 ability to repress gene expression. Consistently, we show that Pax3 and Pax7 inhibit the expression of Dbx1 and of its repressor Prdm12, fate determinants of the V0 and V1 interneurons, respectively. Notably, we provide evidence for the activity of several cis-regulatory modules of Dbx1 to be sensitive to Pax3 and Pax7 transcriptional activity levels. Altogether, our study provides insights into how the redundancy within a TF family, together with discrete dynamics of expression profiles of each member, are exploited to generate cellular diversity. Furthermore, our data supports the model whereby cell fate choices in the neural tube do not rely on binary decisions but rather on inhibition of multiple alternative fates.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dbx1; Neuronal patterning; Pax3/Pax7 transcription factors; Repression; Spinal cord interneurons; cis-regulatory modules

Mesh:

Substances:

Year:  2017        PMID: 28625870     DOI: 10.1016/j.ydbio.2017.06.014

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  5 in total

1.  Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs.

Authors:  Line Manceau; Julien Richard Albert; Pier-Luigi Lollini; Maxim V C Greenberg; Pascale Gilardi-Hebenstreit; Vanessa Ribes
Journal:  PLoS Genet       Date:  2022-05-23       Impact factor: 6.020

2.  Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero.

Authors:  Hong-Ming Zhou; Simon J Conway
Journal:  J Dev Biol       Date:  2022-05-17

Review 3.  PRDM12 in Health and Diseases.

Authors:  Monica Rienzo; Erika Di Zazzo; Amelia Casamassimi; Patrizia Gazzerro; Giovanni Perini; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2021-11-06       Impact factor: 5.923

4.  Precision of morphogen gradients in neural tube development.

Authors:  Roman Vetter; Dagmar Iber
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

5.  The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition.

Authors:  Gloria Gonzalez Curto; Audrey Der Vartanian; Youcef El-Mokhtar Frarma; Line Manceau; Lorenzo Baldi; Selene Prisco; Nabila Elarouci; Frédéric Causeret; Daniil Korenkov; Muriel Rigolet; Frédéric Aurade; Aurélien De Reynies; Vincent Contremoulins; Frédéric Relaix; Orestis Faklaris; James Briscoe; Pascale Gilardi-Hebenstreit; Vanessa Ribes
Journal:  PLoS Genet       Date:  2020-11-11       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.